EARLY HEARING DETECTION AND INTERVENTION VIRTUAL CONFERENCE
MARCH 2-5, 2021
(Virtually the same conference, without elevators, airplane tickets, or hotel room keys)
8/22/2022 | 10:45 AM - 11:10 AM | Partnering for a Purpose: Collaborations to Eliminate CMV | Governor General II
Partnering for a Purpose: Collaborations to Eliminate CMV
Congenital Cytomegalovirus (cCMV), is the most common viral infection and the leading non-genetic cause of infant hearing loss in the United States. Aside from hearing loss, CMV contributes to 1 child being permanently disabled every hour. CMV occurs in about 1 in 200 births (30,000+ per year), yet 91% of women do not know about it. Furthermore, there is no CMV vaccine available, and screening protocols and modalities vary by site. To address these gaps in awareness, screening, and research, the National CMV Foundation (NCMVF) has established and leveraged partnerships with clinicians, pharmaceutical companies, and non-profit organizations to collaborate on education and outreach activities, research efforts, and relevant, accurate and timely information dissemination. This presentation will highlight the significance of effective collaboration and partnerships to fight CMV, through increasing awareness of cCMV and establishing the NCMVF as a respected leader in furthering congenital CMV research.
- Describe best practices for identifyig partners to address CMV screening, awareness and research gaps
- Describe best practices and lessons learned for sustaining partnerships
- Evaluate the effectiveness and impact of NCMVF partnerships
Presentation:
This presentation has not yet been uploaded.
Handouts:
Handout is not Available
Transcripts:
CART transcripts are NOT YET available, but will be posted shortly after the conference
Presenters/Authors
Khaliah Fleming
(), khaliah.fleming@nationalcmv.org;
Executive Director of National CMV Foundation. prof. background includes being results-driven certified health education specialist with international and national public health experience. With background in chronic disease management & prevention, health disparities, health equity & research partnership coordination, she managed & led multiple education& outreach public health programs, teams, & initiatives.
ASHA DISCLOSURE:
Financial -
Nonfinancial -